European Journal of Pediatrics

, Volume 153, Supplement 1, pp S2–S8 | Cite as

Selective screening for inborn errors of metabolism — past, present and future

  • G. F. Hoffmann


Selective screening for hereditary metabolic disorders has developed from a highly specialized activity, provided mostly by research oriented scientists, to an important diagnostic tool in the work-up of paediatric patients. A brief overview is given of the present status of selective screening in Europe, the USA and Israel including the distribution of centres and resources for diagnosis, therapy and follow-up. Current status and most pressing problems vary widely between different countries. Most countries still lack an organized network of clinical genetic centres which are capable of competent and comprehensive diagnostic and therapeutic services. For example, it must be assumed that more than 60% of patients with inherited metabolic diseases, which could be diagnosed nowadays, remain un(mis)diagnosed in former Western Germany. Early diagnosis and treatment are important determinants for a successful approach towards inherited metabolic diseases. Therefore, screening and therapy for inborn errors of metabolism has to be organized in clinical genetic centres, each serving a population between 2 and 4 million. The quality of the services provided depends on good pre-and postgraduate training of physicians (paediatricians) in the field of metabolic diseases, good co-operation between the referring physician and the clinical genetic centre and a broad spectrum of highly specialized metabolic investigations in the respective centre. The institutionalization has to include licensing of laboratories, directors and personnel, as well as quality control and proficiency testing. The size of the centres cannot be judged on the basis of the work involved with selective screening for inborn errors of metabolism alone. The number of diagnosed patients suffering from treatable metabolic disorders, such as those of amino or organic acid metabolism, are cumulative. The patients need lifelong dietary therapy, clinical assessment and biochemical monitoring.

Key words

Inborn errors of metabolism Selective screening Treatment of inherited metabolic diseases Follow up of inherited metabolic diseases Organic acid disorders 


  1. 1.
    Blom W, Huijmans JGM, Berg GB van den (1989) A clinical biochemist's view of the investigation of suspected inherited metabolic disease. J Inherited Metab Dis 12 [Suppl 1]:64–88Google Scholar
  2. 2.
    Connor JM (1989) Genetic aspects of prenatal diagnosis. J Inherited Metab Dis 12 [Suppl 1]:89–96Google Scholar
  3. 3.
    Duran M, Dorland L, Wadman SK, Berger R (1994) Group tests for selective screening of inborn errors of metabolism. Eur J Pediatr [Suppl 1] 153:S27-S32Google Scholar
  4. 4.
    Durand P, Levi E (eds) (1991) Inborn errors of metabolism. European directory of diagnostic laboratories, Instituto Giannina Gaslini, Direzione Scientifica, Largo Gaslini, 5. I-16148 Genova Quarto, ItalyGoogle Scholar
  5. 5.
    Garrod AE (1909) Inborn errors of metabolism: the Croonian lectures delivered before the Royal College of Physicians of London in June 1908. Frowde, Hodder and Stoughtom, LondonGoogle Scholar
  6. 6.
    Green A, Preece MA (1989) In: Schmidt BJ, et al. (eds) Current trends in infant screening. Elsevier, Amsterdam, pp 191–195Google Scholar
  7. 7.
    Hommes FA (1994) Quality control for selective screening of inborn errors of metabolism. Eur J Pediatr [Suppl 1] 153:S17-S22Google Scholar
  8. 8.
    Lehnert W (1994) Long-term results of selective screening for inborn errors of metabolism. Eur J Pediatr [Suppl 1] 153:S9-S13Google Scholar
  9. 9.
    Machill G, Grimm U, Ahlberendt I, Bührdel P, Tittelbach-Helmrich W, Naumann A, Böhme HJ, Seidlitz G, Schneider T (1994) Results of selective screening for inborn errors of metabolism in former East-Germany. Eur J Pediatr [Suppl 1] 153:S14-S16Google Scholar
  10. 10.
    Saudubray JM, Ogier H, Bonnefont JP, Munnich A, Lombes A, Herve F, Mitchel G, Poll Thé B, Specola N, Parvy P, Bardet J, Rabier D, Coudé M, Charpentier C, Frézal J (1989) Clinical approach to inherited metabolic diseases in the neonatal period: a 20-year survey. J Inherited Metab Dis 12 [Suppl 1]:25–41Google Scholar
  11. 11.
    Scriver CR, Beaudet AL, Sly WS, Valle D (eds) (1989) The metabolic basis of inherited disease. McGraw Hill, New YorkGoogle Scholar
  12. 12.
    Stanbury CR, Wyngarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) (1983) The metabolic basis of inherited disease. McGraw Hill, New YorkGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • G. F. Hoffmann
    • 1
  1. 1.Abteilung für PädiatrieUniversität HeidelbergHeidelbergGermany

Personalised recommendations